Jefferies Downgrades Five Prime Therapeutics (FPRX) to Hold
Tweet
Share
E-mailGet Alerts FPRX Hot Sheet
Price: $38.00 --0%
Rating Summary:
9 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
9 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Jefferies analyst Eun Yang downgraded Five Prime Therapeutics (NASDAQ: FPRX) from Buy to Hold with a price target of $38.00.
For an analyst ratings summary and ratings history on Five Prime Therapeutics click here. For more ratings news on Five Prime Therapeutics click here.
Shares of Five Prime Therapeutics closed at $38.00 yesterday.
You May Also Be Interested In
- Wells Fargo Downgrades Roku Inc. (ROKU) to Equal Weight
- Citizens Downgrades SoundThinking (SSTI) to Market Perform
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
